18F-DOPA II - PET Imaging Optimization

Abroad (travel likely)RecruitingPHASE3

Conditions

Congenital Hyperinsulinism · Neuroblastoma · Parkinson Disease · Lewy Body Disease · Neuroendocrine Tumors · Brain Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

WC Mackenzie Health Science Centre / University of Alberta Hospital, Edmonton, Alberta, Canada
Contact: Study coordinator (Jonathan Abele, MD) · jabele@ualberta.ca · 780-407-6907

Study leads

Jonathan Abele, MD
Principal Investigator
University of Alberta

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

Congenital Hyperinsulinism

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Hyperinsulinism

Abroad (travel likely)RecruitingPHASE2

St Louis, United States

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

PCOS · Hyperinsulinism · Hyperandrogenism

Abroad (travel likely)Recruiting

Chaïdári, Greece